Articles from Law Offices of Howard G. Smith

Law Offices of Howard G. Smith reminds investors of the upcoming March 31, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased TELUS International (Cda) Inc. (“Telus International” or the “Company”) (NYSETIXT) securities between February 16, 2023 and August 1, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming March 31, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased ModivCare, Inc. (“ModivCare” or the “Company”) (NASDAQMODV) securities between November 3, 2022 and September 15, 2024, inclusive (the “Class Period”). ModivCare investors have until March 31, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith reminds investors of the upcoming March 24, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) common stock between November 3, 2022 and October, 28 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased TELUS International (Cda) Inc. (“Telus International” or the “Company”) (NYSETIXT) securities between February 16, 2023 and August 1, 2024, inclusive (the “Class Period”). Telus International investors have until March 31, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces an investigation on behalf of ModivCare, Inc. (“ModivCare” or the “Company”) (NASDAQMODV) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”). IAS investors have until March 31, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces an investigation on behalf of Construction Partners, Inc. (“Construction Partners” or the “Company”) (NASDAQROAD) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of Triumph Financial, Inc. (“Triumph” or the “Company”) (NASDAQTFIN) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) common stock between November 3, 2022 and October, 28 2024, inclusive (the “Class Period”). Crocs investors have until March 24, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith reminds investors of the upcoming March 18, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) securities between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces an investigation on behalf of Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith reminds investors of the upcoming March 18, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Block, Inc. (“Block” or the “Company”) (NYSE: SQ; XYZ) Class A common stock between February 26, 2020 and April 30, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) securities between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”). FTAI investors have until March 18, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Block, Inc. (“Block” or the “Company”) (NYSE: SQ; XYZ) Class A common stock between February 26, 2020 and April 30, 2024, inclusive (the “Class Period”). Block investors have until March 18, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces an investigation on behalf of TELUS International (Cda) Inc. (“TELUS” or the “Company”) (NYSETIXT) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of PVH Corp. (“PVH” or the “Company”) (NYSEPVH) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQCDLX) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith reminds investors of the upcoming March 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQBIOA) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s September 2024 initial public offering (the “IPO” or the “Offering”).

Law Offices of Howard G. Smith reminds investors of the upcoming March 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQREGN) securities between November 2, 2023 and October 30, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces an investigation on behalf of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or the “Company”) (NYSEHII) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQPGNY) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith reminds investors of the upcoming February 25, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQNXT) common stock between February 1, 2024 and August 1, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQREGN) securities between November 2, 2023 and October 30, 2024, inclusive (the “Class Period”). Regeneron investors have until March 10, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQBIOA) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s September, 2024 initial public offering (the “IPO” or the “Offering”). BioAge investors have until March 10, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces an investigation on behalf of BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQBIOA) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith reminds investors of the upcoming March 4, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQRVNC) securities between February 29, 2024 and December 6, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming February 21, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Capri Holdings Limited (“Capri” or the “Company”) (NYSECPRI) securities or sold puts between August 10, 2023 and October 24, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming February 18, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Joint Stock Company Kaspi.kz (“Kaspi” or the “Company”) (NASDAQKSPI) securities between January 19, 2024 and September 19, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming February 21, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) securities between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQNXT) common stock between February 1, 2024 and August 1, 2024, inclusive (the “Class Period”). Nextracker investors have until February 25, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQRVNC) securities between February 29, 2024 and December 6, 2024, inclusive (the “Class Period”). Revance investors have until March 4, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith reminds investors of the upcoming February 18, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces an investigation on behalf of Sangamo Therapeutics, Inc. (“Sangamo” or the “Company”) (NASDAQSGMO) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Joint Stock Company Kaspi.kz (“Kaspi” or the “Company”) (NASDAQKSPI) securities between January 19, 2024 and September 19, 2024, inclusive (the “Class Period”). Kaspi investors have until February 18, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) securities between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”). AstraZeneca investors have until February 21, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Capri Holdings Limited (“Capri” or the “Company”) (NYSECPRI) securities or sold puts between August 10, 2023 and October 24, 2024, inclusive (the “Class Period”). Capri investors have until February 21, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith reminds investors of the upcoming February 24, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Transocean Ltd. (“Transocean” or the “Company”) (NYSERIG) securities between October 31, 2023 and September 2, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces an investigation on behalf of Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQNXT) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). Applied Therapeutics investors have until February 18, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces an investigation on behalf of Capri Holdings Limited (“Capri” or the “Company”) (NYSECPRI) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Transocean Ltd. (“Transocean” or the “Company”) (NYSERIG) securities between October 31, 2023 and September 2, 2024, inclusive (the “Class Period”). Transocean investors have until February 24, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith reminds investors of the upcoming February 14, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased MGP Ingredients, Inc. (“MGPI” or the “Company”) (NASDAQMGPI) common stock between May 4, 2023 through October 30, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming February 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Sun Communities, Inc. (“Sun Communities” or the “Company”) (NYSESUI) securities between February 28, 2019 and September 24, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming February 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQKYTX) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s February 2024 initial public offering (the “IPO” or the “Offering”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Sun Communities, Inc. (“Sun Communities” or the “Company”) (NYSESUI) securities between February 28, 2019 and September 24, 2024, inclusive (the “Class Period”). Sun Communities investors have until February 10, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased MGP Ingredients, Inc. (“MGPI” or the “Company”) (NASDAQMGPI) common stock between May 4, 2023 through October 30, 2024, inclusive (the “Class Period”). MGPI investors have until February 14, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) securities between June 4, 2024 and August 8, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming February 4, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased DMC Global Inc. (“DMC” or the “Company”) (NASDAQBOOM) securities between May 3, 2024 and November 4, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming February 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQMQ) securities between May 7, 2024 and November 4, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) securities between June 4, 2024 and August 8, 2024, inclusive (the “Class Period”). Five9 investors have until February 3, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQKYTX) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s February 2024 initial public offering (the “IPO” or the “Offering”). Kyverna investors have until February 7, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces an investigation on behalf of Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQKYTX) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith reminds investors of the upcoming January 31, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) securities between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQAEHR) securities between January 9, 2024 and March 24, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased DMC Global Inc. (“DMC” or the “Company”) (NASDAQBOOM) securities between May 3, 2024 and November 4, 2024, inclusive (the “Class Period”). DMC investors have until February 4, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQMQ) securities between May 7, 2024 and November 4, 2024, inclusive (the “Class Period”). Marqeta investors have until February 7, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) securities between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”). Customers Bancorp investors have until January 31, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces an investigation on behalf of Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQAEHR) securities between January 9, 2024 and March 24, 2024, inclusive (the “Class Period”). Aehr investors have until February 3, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). ASP Isotopes investors have until February 3, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith reminds investors of the upcoming January 27, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Rentokil Initial plc (“Rentokil” or the “Company”) (NYSERTO) American Depositary Shares (“ADSs”) between December 1, 2023 and September 10, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQSYM) securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces an investigation on behalf of Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQAEHR) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQSYM) securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”). Symbotic investors have until February 3, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Rentokil Initial plc (“Rentokil” or the “Company”) (NYSERTO) American Depositary Shares (“ADSs”) between December 1, 2023 and September 10, 2024, inclusive (the “Class Period”). Rentokil investors have until January 27, 2025 to file a lead plaintiff motion.

Law Offices of Howard G. Smith reminds investors of the upcoming January 24, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Match Group, Inc. (“Match Group” or the “Company”) (NASDAQMTCH) securities between May 2, 2023 and November 6, 2024, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces an investigation on behalf of Rentokil Initial plc (“Rentokil” or the “Company”) (NYSERTO) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQCELH) investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of ASP Isotopes Inc. (“ASPI” or the “Company”) (NASDAQASPI) investors concerning the Company’s possible violations of federal securities laws.